Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Warrants Presented at Fair Value (Tables)

v3.23.1
Warrants Presented at Fair Value (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of outstanding warrants classified as a liability
Outstanding     Exercise
price
    Issuance
year
   

Exercisable

through

    Fair value      
                               
  120,000     $ 0.92 (*)     2014       (***)   $ 1     (****)
  675,926       (** )     2017       2024       14,785     (****)
  1,411,765       0.17       2019       2024       673     See Note 8.e.
                                         
  2,207,691                             $ 15,459     (*****)

 

(*) Subject to changes as describe in the agreement.

 

(**) Less than $0.01.

 

(***) M&A or qualified public offering as described in the agreement.

 

(****) Issued in connection with the 2014 through 2017 financing rounds.

 

(*****) Contains warrants presented at fair value within non-current liabilities.

 

Outstanding     Exercise
price
    Issuance
year
   

Exercisable

through

    Fair value      
                               
  120,000     $ 0.92 (*)     2014       (***)   $ 94     (****)
  905,555       0.17       2017       2022       5,841     See Note 8.a.
  436,666       1.50       2017       2022       2     (****)
  33,332       1.20       2017       2022           (****)
  33,332       1.00       2017       2022           (****)
  675,926       (** )     2017       2024       54,731     (****)
  11,111       1.20       2017       2022           (****)
  1,659,971       0.17       2018       2022       11,359     See Note 8.a.
  1,411,765       0.17       2019       2024       34,948     See Note 8.e.
                                         
  5,287,658                             $ 106,975     (*****)

 

(*) Subject to changes as described in the agreement.

 

(**) Less than $0.01.

 

(***) M&A or qualified public offering as described in the agreement.

 

(****) Issued in connection with the 2014 through 2017 financing rounds.

 

(*****)

Contains warrants presented at fair value within current liabilities of $17,296 and within non-current liabilities of $89,679.